Sichuan Kelun Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000PW7
CNY
33.64
-0.39 (-1.15%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
4,259.24
5,236.19
4,193.40
4,693.43
4,389.90
5,023.64
4,961.67
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,259.24
5,236.19
4,193.40
4,693.43
4,389.90
5,023.64
4,961.67
Raw Material Cost
2,329.22
2,801.53
2,420.45
2,391.53
2,334.50
2,625.32
2,574.87
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
23.12
19.09
29.99
27.23
26.52
28.03
34.09
Selling and Distribution Expenses
1,006.14
1,126.88
1,006.97
1,101.70
899.10
1,214.42
1,043.67
Other Expenses
56.30
51.53
51.61
49.61
41.69
52.15
43.50
Total Expenditure (Excl Depreciation)
3,921.50
4,462.77
3,973.55
4,016.58
3,677.02
4,389.23
4,087.66
Operating Profit (PBDIT) excl Other Income
337.70000000000005
773.4000000000001
219.8
676.9
712.9000000000001
634.4
874
Other Income
130.71
90.60
65.36
57.40
73.89
87.22
4.15
Operating Profit (PBDIT)
397.80
1,103.71
577.07
951.93
1,086.27
889.83
1,137.57
Interest
23.12
19.09
29.99
27.23
26.52
28.03
34.09
Exceptional Items
7.20
3.78
6.28
7.51
7.63
6.22
8.21
Gross Profit (PBDT)
1,930.02
2,434.66
1,772.95
2,301.90
2,055.40
2,398.32
2,386.80
Depreciation
0.00
357.42
357.42
352.77
352.77
335.63
335.63
Profit Before Tax
381.88
730.97
195.94
579.43
714.60
532.39
776.06
Tax
-31.65
122.46
100.37
190.20
113.60
138.75
135.37
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
453.70
501.27
200.04
416.38
584.24
464.96
670.82
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
453.70
501.27
200.04
416.38
584.24
464.96
670.82
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
19.00
131.17
-69.13
37.89
75.34
-24.02
34.41
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
472.70
632.44
130.91
454.27
659.59
440.95
705.23
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
24,638.16
24,224.47
23,707.84
23,679.23
23,094.46
22,479.52
22,555.03
Earnings per share (EPS)
0.29
0.32
0.13
0.26
0.37
0.29
0.42
Diluted Earnings per share
0.29
0.32
0.13
0.26
0.37
0.29
0.42
Operating Profit Margin (Excl OI)
6.27%
12.52%
3.68%
11.54%
15.03%
9.3%
16.08%
Gross Profit Margin
8.97%
20.79%
13.2%
19.86%
24.31%
17.28%
22.41%
PAT Margin
10.65%
9.57%
4.77%
8.87%
13.31%
9.26%
13.52%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is -2.98% vs -29.42% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is -28.34% vs -48.70% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -73.62% vs -41.67% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is -12.83% vs -44.33% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of Sichuan Kelun Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
4,259.24
0
4,259.24
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,259.24
0
4,259.24
Raw Material Cost
2,329.22
0
2,329.22
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
23.12
0
23.12
Selling and Distribution Expenses
1,006.14
0
1,006.14
Other Expenses
56.30
0.00
56.30
Total Expenditure (Excl Depreciation)
3,921.50
0
3,921.50
Operating Profit (PBDIT) excl Other Income
337.74
0.00
337.74
Other Income
130.71
0
130.71
Operating Profit (PBDIT)
397.80
0
397.80
Interest
23.12
0
23.12
Exceptional Items
7.20
0
7.20
Gross Profit (PBDT)
1,930.02
0
1,930.02
Depreciation
0.00
0
0.00
Profit Before Tax
381.88
0
381.88
Tax
-31.65
0
-31.65
Provisions and contingencies
0
0
0.00
Profit After Tax
453.70
0
453.70
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
453.70
0
453.70
Share in Profit of Associates
0
0
0.00
Minority Interest
19.00
0
19.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
472.70
0
472.70
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
24,638.16
0
24,638.16
Earnings per share (EPS)
0.29
0
0.29
Diluted Earnings per share
0.29
0
0.29
Operating Profit Margin (Excl OI)
6.27%
0%
0.00
6.27%
Gross Profit Margin
8.97%
0%
0.00
8.97%
PAT Margin
10.65%
0%
0.00
10.65%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 425.92 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -18.66% vs 24.87% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -2.98% vs -29.42% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 47.27 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -25.25% vs 383.12% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -28.34% vs -48.70% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.71 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -73.64% vs 97.99% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -73.62% vs -41.67% in Mar 2025

Quarterly - Interest
Interest 2.31 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 20.94% vs -36.33% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -12.83% vs -44.33% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.27%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025